PAUL FIDRYCH: Open Payments
NPI 1972121630 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,537 in 279 payments from 35 companies in 2025. Trend: 2023 $5,910 · 2024 $5,654 · 2025 $6,537
Food & beverage: $6,481Education: $56
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $809 |
| Novartis Pharmaceuticals Corporation | 27 | $780 |
| EMD Serono, Inc. | 21 | $644 |
| UCB, Inc. | 15 | $434 |
| PFIZER INC. | 19 | $395 |
| Amgen Inc. | 14 | $362 |
| Lundbeck LLC | 14 | $335 |
| Biogen, Inc. | 16 | $330 |
| TG Therapeutics, Inc. | 8 | $276 |
| Eisai Inc. | 10 | $194 |
Products named: KESIMPTA, TYSABRI, VYEPTI, UBRELVY, NURTEC ODT, BRIUMVI, UPLIZNA, BOTOX.
Industry payments across CT — which companies pay providers there.
